Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Affiliation
Genito-urinary cancer research group, Division of Cancer Sciences, Manchester Cancer Research Centre, University of ManchesterIssue Date
2018-05-19
Metadata
Show full item recordAbstract
To determine the prognostic relevance of non-regional lymph node (NRLN) metastases presenting synchronously with bone metastases in metastatic prostate cancer (mPCa) for guiding treatment decisions based on oligometastatic definitions.Citation
Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer. 2018, BJU IntJournal
BJU InternationalDOI
10.1111/bju.14400PubMed ID
29777564Type
ArticleLanguage
enISSN
1464-410Xae974a485f413a2113503eed53cd6c53
10.1111/bju.14400